Abstract
Cytosolic sulfotransferases (SULTs) catalyze the sulfate conjugation of a myriad of endogenous and xenobiotic substrates. Among the 13 human SULTs, little is known regarding regulation of the SULT1C subfamily. We evaluated the effects of a panel of transcription factor activators on levels of SULT1C mRNA (1C2 and 1C3) and protein (1C2) in LS180 colorectal adenocarcinoma cells. Treatment with 3-[3-[N-(2-chloro-3-trifluoromethylbenzyl)-(2,2-diphenylethyl)amino]propyloxy]phenylacetic acid hydrochloride [GW3965, liver X receptor (LXR) activator], 3-(2,6-dichlorophenyl)-4-(3'-carboxy-2-chlorostilben-4-yl)oxymethyl-5-isopropylisoxazole [GW4064, farnesoid X receptor (FXR)], or rifampicin [pregnane X receptor (PXR)] moderately (≤2-fold) increased both SULT1C2 and SULT1C3 mRNA levels. 1α,25-Dihydroxyvitamin D3 [1,25(OH)2D3, vitamin D receptor (VDR)] selectively upregulated SULT1C2, whereas ciprofibrate [peroxisome proliferator-activated receptor α (PPARα)], rosiglitazone (PPARγ), and 2,3,7,8-tetrachlorodibenzo-p-dioxin [aryl hydrocarbon receptor (AhR)] selectively increased SULT1C3 mRNA levels. SULT1C2 protein content was strongly increased by 1,25(OH)2D3 treatment and moderately increased by GW3965, GW4064, and rifampicin. To evaluate ...Continue Reading
References
May 1, 1997·Genomics·C HerR M Weinshilboum
Dec 16, 1998·The Journal of Biological Chemistry·Y SakakibaraM C Liu
Apr 28, 2000·Genomics·R R FreimuthR M Weinshilboum
Oct 12, 2000·Biochemical and Biophysical Research Communications·T P DooleyT W Wilborn
Nov 15, 2000·Biochemical Pharmacology·X LiR J Anderson
Jan 13, 2001·Chemico-biological Interactions·H Glatt
Jan 24, 2002·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Yunfei WangXifeng Wu
Oct 10, 2002·Endocrine Reviews·Charles A Strott
Apr 30, 2003·Molecular Cell·Michael DownesRonald M Evans
May 20, 2003·The Journal of Biological Chemistry·Parinaz C PircherStefan K Westin
Nov 19, 2003·The Journal of Steroid Biochemistry and Molecular Biology·Takashi SuzukiHironobu Sasano
Dec 17, 2003·The Pharmacogenomics Journal·R R FreimuthR M Weinshilboum
Feb 24, 2004·Molecular Pharmacology·Ibtissam EchchgaddaBandana Chatterjee
May 29, 2004·Pharmacogenetics·Rebecca L BlanchardMichael W H Coughtrie
Jan 7, 2005·Molecular Pharmacology·Hai-Lin FangMelissa Runge-Morris
Apr 29, 2005·Journal of Medicinal Chemistry·William J ZuercherTimothy M Willson
Apr 30, 2005·Bioinformatics·K CarthariusT Werner
Jul 19, 2005·Molecular and Cellular Endocrinology·Emma L StanleyMichael W H Coughtrie
Sep 10, 2005·Journal of Lipid Research·Yan J JiangKenneth R Feingold
Dec 3, 2005·Toxicological Sciences : an Official Journal of the Society of Toxicology·Niranjali GamageMichael E McManus
Feb 4, 2006·Current Drug Metabolism·Li-Quan Wang, Margaret O James
Mar 22, 2006·Oncogene·S Nowell, C N Falany
Sep 2, 2006·Drug Metabolism and Pharmacokinetics·Masaaki MiyataYasushi Yamazoe
Apr 12, 2007·PLoS Biology·Abdellah Allali-HassaniCheryl H Arrowsmith
Jun 28, 2007·Molecular Endocrinology·Ibtissam EchchgaddaBandana Chatterjee
Aug 10, 2007·The Journal of Pharmacology and Experimental Therapeutics·Hai-Lin FangMelissa Runge-Morris
Oct 16, 2007·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Walter MeinlHansruedi Glatt
Feb 22, 2008·Current Drug Metabolism·Julian LindsayShu-Feng Zhou
Mar 6, 2008·Cancer·Hiroshi HirataRajvir Dahiya
Mar 12, 2008·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Anshul GuptaJashvant D Unadkat
Nov 8, 2008·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Michelle CotterchioPatricia A Harper
Aug 15, 2009·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Zoe RichesMichael W H Coughtrie
Aug 15, 2009·PPAR Research·Melissa Runge-Morris, Thomas A Kocarek
Apr 16, 2011·Molecular Endocrinology·Shailendra Kumar Dhar DwivediSabyasachi Sanyal
Jul 19, 2011·Nucleic Acids Research·Susumu KodamaMasahiko Negishi
Nov 24, 2011·Molecular Endocrinology·Mark B MeyerJ Wesley Pike
Jan 22, 2013·Drug Metabolism Reviews·Melissa Runge-MorrisCharles N Falany
Jan 26, 2013·Inflammatory Bowel Diseases·Joana TorresSteven H Itzkowitz
Dec 18, 2013·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Zofia Duniec-DmuchowskiThomas A Kocarek
Citations
Jan 2, 2016·Oncology Letters·Jiahui NingLuchen Xue
Apr 25, 2016·The Journal of Steroid Biochemistry and Molecular Biology·Tatiana Claro da SilvaGerd A Kullak-Ublick
May 14, 2016·Chemico-biological Interactions·Michael W H Coughtrie
May 1, 2016·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Kathleen G BarrettMelissa Runge-Morris
Aug 28, 2016·Molecular Pharmacology·Sarah DubaisiMelissa Runge-Morris
Aug 9, 2017·FEBS Letters·Shujun XieDajing Xia
Sep 21, 2017·The Journal of Pharmacology and Experimental Therapeutics·Elizabeth A RondiniJames G Granneman
Jun 3, 2018·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Sarah DubaisiMelissa Runge-Morris
Dec 18, 2013·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Zofia Duniec-DmuchowskiThomas A Kocarek
May 8, 2015·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Kathleen G BarrettMelissa Runge-Morris
Oct 3, 2015·The Journal of Pharmacology and Experimental Therapeutics·Elizabeth A RondiniThomas A Kocarek
Jun 21, 2016·Oncotarget·Ada W. Y. LeungMarcel B Bally
Apr 19, 2020·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Sarah DubaisiMelissa Runge-Morris
Aug 28, 2019·Oncology Letters·Ye FengZhi Chen